Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab

NEXT STORY
Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance
PREV STORY
Retrophin Provides Corporate Update and 2020 Outlook
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

Updated label may allow for increased dosing flexibility for patients with hyperkalemia (elevated blood ...

author_avatar
NASDAQ Market News

Vaxil Granted First U.S. Patent for Its Cancer Immunotherapy Antibody Platform

NESS-ZIONA, ISRAEL--(Marketwired - March 01, 2018) - VAXIL BIO LTD. (TSX VENTURE: VXL), an ...

author_avatar
NASDAQ Market News

Spring Bank Pharmaceuticals Appoints Dr. Todd C. Brady to its Board of Directors

MILFORD, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a ...

author_avatar
NASDAQ Market News